FOX04-DRI

FOX04-DRI (FOXO4-D-Retro-Inverso) is a senolytic peptide that targets and eliminates senescent cells — aged, damaged cells that refuse to die and instead release inflammatory signals that damage surrounding tissue. By clearing these “zombie cells,” FOX04-DRI promotes tissue rejuvenation. Supplied as lyophilized powder with ≥98% purity (HPLC-verified).

Cómo funciona

As we age, damaged cells enter a state called senescence. They don’t divide, but they don’t die either — they hang around releasing inflammatory chemicals that damage nearby healthy cells and accelerate aging. FOX04-DRI works by blocking the interaction between FOXO4 (a protein that keeps senescent cells alive) and p53 (the cell’s suicide switch). When this interaction is blocked, senescent cells finally undergo apoptosis — programmed cell death — making room for healthy cells.

Datos de investigación

• Senescent cell clearance: Research demonstrates FOX04-DRI selectively kills senescent cells while leaving healthy cells untouched — the holy grail of senolytic therapy.
• Tissue rejuvenation: In aging mouse studies, FOX04-DRI treatment restored fur density (hair regrowth), improved kidney function, and increased spontaneous activity — effects consistent with multi-tissue rejuvenation.
• Chemotherapy recovery: Research shows FOX04-DRI counteracts chemotherapy-induced senescence and toxicity, reducing both the short-term damage and the long-term accelerated aging caused by cancer treatment.
• Frailty reduction: Senescent cell clearance is associated with improved physical function, grip strength, and overall vitality in aging models.
• Inflammaging: By removing senescent cells, FOX04-DRI reduces the chronic low-grade inflammation that characterizes aging — known as “inflammaging.”
• Life quality: Unlike lifespan extension studies that focus on maximum lifespan, FOX04-DRI focuses on healthspan — extending the period of healthy, functional life.

Aplicaciones de la investigación

• Senolytic pharmacology and cellular senescence
• Aging and healthspan research
• Chemotherapy toxicity and recovery
• Inflammaging and chronic inflammation

Especificaciones del producto

• Pureza: ≥98% (HPLC)
• Forma: Polvo liofilizado
• Solubilidad: Reconstituir en agua bacteriostática estéril

Almacenamiento y manipulación

• Almacene el péptido liofilizado a -20°C, protegido de la luz y la humedad.
• Después de la reconstitución, alícuote y almacene a -20°C. Evite ciclos repetidos de congelación y descongelación.

Descargo de responsabilidad: Este producto está destinado exclusivamente para fines de laboratorio e investigación. No es un medicamento, suplemento dietético o producto alimenticio. No para uso humano o veterinario.

Lo que dice Internet

Esto es lo que discuten las comunidades en línea. No es un consejo médico, solo para uso en investigación de laboratorio.

Revuelo en la comunidad

FOX04-DRI is “the zombie cell killer” — one of the most discussed longevity peptides in biohacking circles. As a senolytic, it selectively clears senescent “zombie” cells — old cells that refuse to die and instead leak inflammatory signals that age surrounding tissue. The community protocol: FOX04-DRI first (2mg EOD for 5 doses, then 5mg EOD for 8 doses) to clear senescent cells, then follow with BPC-157 y TB-500 for tissue recovery, then SS-31 y MOTS-C for mitochondrial health, and finally Thymalin y Epithalon for general longevity. The logic: clear the old cells first, then rebuild and protect what remains.

Por qué la gente está interesada

• Clears senescent cells that drive aging. Zombie cells cause inflammation and tissue dysfunction — FOX04-DRI removes them.
• Reduces age-related inflammation. Fewer senescent cells = less inflammatory signaling throughout the body.
• First step in comprehensive longevity protocols. Clear old cells, then rebuild with healing and mitochondrial peptides.

⚠️ Senolytic therapy is experimental with no long-term human data. Community protocols are experimental. This information is for awareness only.